We have previously reported that in patients with severe RA undergoing anti-TNF-alpha therapy high-grade inflammation was independently and negatively correlated with circulating adiponectin concentrations whereas low adiponectin levels clustered with metabolic syndrome features that reportedly contribute to atherogenesis in RA [96]. This evidence concerns the gene TNF and rheumatoid arthritis.